Publication | Closed Access

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletCoronary Artery DiseasePlatelet AntagonistCardiologyPharmacotherapyAcute Myocardial InfarctionCoronary StentingAntiplatelet EffectsMedicineAnticoagulantAtherosclerosisEmergency MedicineAnesthesiology